Literature DB >> 29151167

Prenatal ultrasonographic detection and prenatal (prior to birth) management of hereditary retinoblastoma.

Christina Stathopoulos1,2, Emil Anthony T Say1, Carol L Shields3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29151167     DOI: 10.1007/s00417-017-3841-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Antenatal ophthalmology.

Authors:  Sharon S Lehman
Journal:  J AAPOS       Date:  2003-12       Impact factor: 1.220

2.  In vivo growth of retinoblastoma in a newborn infant.

Authors:  Parag K Shah; V Narendran; N Kalpana
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

3.  Fetal retinoblastoma.

Authors:  A Salim; G H Wiknjosastro; D Danukusumo; B Barnas; I Zalud
Journal:  J Ultrasound Med       Date:  1998-11       Impact factor: 2.153

4.  Managing fetuses at high risk of retinoblastoma: lesion detection on screening MRI.

Authors:  Sandra E Staffieri; George McGillivray; James E Elder; Amber Bristowe; Stephen Cole; John D McKenzie; A Michelle Fink
Journal:  Prenat Diagn       Date:  2014-11-27       Impact factor: 3.050

5.  In utero detection of retinoblastoma with fetal magnetic resonance and ultrasound: initial experience.

Authors:  Lisa B Paquette; David Miller; Hollie A Jackson; Thomas Lee; Linda Randolph; A Lynn Murphree; Ashok Panigrahy
Journal:  AJP Rep       Date:  2012-07-16
  5 in total
  2 in total

Review 1.  Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges.

Authors:  Rabin Neupane; Ripal Gaudana; Sai H S Boddu
Journal:  AAPS J       Date:  2018-09-05       Impact factor: 4.009

2.  Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks.

Authors:  Yukun Mao; Qingbin Nie; Yang Yang; Gengsheng Mao
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.